1 completed, 1 not yet recruiting. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Provepharm SAS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients Indigotindisulfonate sodium 0.8% injection - Ureter Injury | Phase 3 | Not yet recruiting | Prove pharm | 18 | 2026-12-01 | 2026-10-16 |
| MEthylene Blue In Patients With Acquired Methemoglobinemia Methylene Blue - Acquired Methaemoglobinaemia | Phase 4 | Completed | Provepharm SAS | 7 | 2018-07-06 | 2023-04-10 |
Indigo Carmine (1) · Injections (1) · Methylene Blue (1)
France (1)
Bruno Megarbane (1) · Lisa Schwartz (1)
2017 (1)